Consensus CONMED Corporation

Equities

CNMD

US2074101013

Real-time Estimate Cboe BZX Other stock markets 16:47:29 01/05/2024 BST			5-day change	1st Jan Change
67.66 ^USD	-0.47%		-3.66%	-38.41%

04-25	Wells Fargo Adjusts Price Target on CONMED to $77 From $98, Maintains Equalweight Rating	MT
04-25	Needham Lowers Price Target on CONMED to $107 From $129, Notes Slight Guidance Cut Due to Currency, Keeps Buy Rating	MT

Evolution of the average Target Price on CONMED Corporation

Price target over the last 5 years

History of analyst recommendation changes

187b26043d35941fcf09df8.NhYOeF33SniBAzC1BPL-j3b66cXNBT-tmFtFiwHIeKI.V093GRq1E03TW1WGTcWV5R2ooraobGno3Tknz3GHL_oCWzwsbIQvH9JnYQ~872548549853e04fca6c6a6a8cb281e7

Analyst Recommendations on CONMED Corporation

Wells Fargo Adjusts Price Target on CONMED to $77 From $98, Maintains Equalweight Rating	04-25	MT
Needham Lowers Price Target on CONMED to $107 From $129, Notes Slight Guidance Cut Due to Currency, Keeps Buy Rating	04-25	MT
Needham Adjusts Price Target on CONMED to $129 From $119, Maintains Buy Rating	02-01	MT
JPMorgan Cuts CONMED Price Target to $115 From $135, Maintains Overweight Rating	02-01	MT
Piper Sandler Adjusts Price Target on CONMED to $130 From $145, Maintains Overweight Rating	27/10/23	MT
Wells Fargo Cuts Price Target on CONMED to $107 From $123, Maintains Equalweight Rating	26/10/23	MT
Needham Adjusts Price Target on CONMED to $140 From $139, Maintains Buy Rating	27/07/23	MT
Keybanc Adjusts Price Target on CONMED to $141 From $131, Maintains Overweight Rating	27/07/23	MT
Needham Raises Price Target on CONMED to $139 From $135, Keeps Buy Rating	05/06/23	MT
CL King Starts CONMED at Buy With $140 Price Target	22/05/23	MT
Piper Sandler Raises CONMED's Price Target to $128 From $118, Maintains Overweight Rating	27/04/23	MT
Wells Fargo Adjusts Price Target on CONMED to $119 From $96, Maintains Equal-Weight Rating	27/04/23	MT
Needham Adjusts Price Target on CONMED to $135 From $122, Reiterates Buy Rating	27/04/23	MT
Keybanc Adjusts Price Target on CONMED to $131 From $124, Maintains Overweight Rating	27/04/23	MT
CONMED Upgraded by KeyBanc to Overweight From Sector Weight, Price Target Set at $124; Firm Sees Financial Profile Improving	27/03/23	MT
ANALYST RECOMMENDATIONS : Caterpillar, Conmed, Corning, Model N, United Rentals...	27/03/23
Needham Raises Price Target on CONMED to $122 From $106, Maintains Buy Rating	03/02/23	MT
Piper Sandler Adjusts CONMED's Price Target to $118 From $108, Maintains Overweight Rating	03/02/23	MT
Needham Cuts Price Target on CONMED to $90 From $123, Citing Currency Headwind, Inflation, Peer Multiple Contraction; Buy Rating Kept	14/10/22	MT
Jefferies Starts CONMED at Hold With $85 Price Target	12/10/22	MT
Needham Trims CONMED's Price Target to $123 From $127 on Near-Term Earnings Dilution From Biorez Deal; Buy Rating Kept	02/08/22	MT
Piper Sandler Adjusts CONMED's Price Target to $118 From $160, Reiterates Overweight Rating	28/07/22	MT
Needham Adjusts CONMED's Price Target to $127 From $155, Noting Currency Headwinds, Keeps Buy Rating Amid Accelerating Growth	28/07/22	MT
Stifel Nicolaus Adjusts Price Target for CONMED to $110 From $160, Maintains Buy Rating	23/06/22	MT
Needham Lifts CONMED's Price Target to $155 From $150 on In2Bones Acquisition, Reiterates Buy Rating	05/05/22	MT